source
- Eli Lilly halts phase 2 Alzheimer's trial of mevidalen after missing internal targetsEli Lilly announced it is removing mevidalen from its pipeline, ending a phase 2 trial in symptomatic Alzheimer's disease. The decision was disclosed during the company's third-quarter earnings up…
- Biopharma job postings in New York surge 109% year over year, eight firms hiringBioSpace data shows that biopharma job postings in New York have surged, rising 109% from Oct 1 2025 to Oct 26 2026, with month‑over‑month gains of 32% in August‑September and 19% in September‑Octo…